RBC Capital Downgrades Vivus (VVUS) to Sector Perform
Get Alerts VVUS Hot Sheet
Rating Summary:
3 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 14 | New: 22
Join SI Premium – FREE
RBC Capital downgraded Vivus (NASDAQ: VVUS) from Outperform to Sector Perform with a price target of $1.00 (from $4.00).
Analyst Simos Simeonidis commented, "Despite having the strongest anti-obesity agent, Vivus has been plagued by numerous issues, which have little to do with the drug's activity, but rather with IP, commercialization, the obesity market itself, the company's liquidity etc. We similarly view Stendra as a differentiated, attractive asset in the $4.5B ED space. However, we expect these issues to persist and we thus downgrade VVUS to SP."
For an analyst ratings summary and ratings history on Vivus click here. For more ratings news on Vivus click here.
Shares of Vivus closed at $1.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
- HSBC Upgrades Covivio (COV:FP) to Buy
- Omega Healthcare Investors (OHI) PT Raised to $32 at Citi
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!